Primary Site >> Stomach Cancer
Gene >> ERBB3
| 1. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 1993 May 14;192(3):1189-97. | ||||||||||
| Title: | c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase. | ||||||||||
| Author: | Katoh, M|Yazaki, Y|Sugimura, T|Terada, M | ||||||||||
| PMID: | 7685162 | ||||||||||
| 2. | |||||||||||
| Journal: | Gastroenterology. 1999 Nov;117(5):1119-27. | ||||||||||
| Title: | Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. | ||||||||||
| Author: | Noguchi, H|Sakamoto, C|Wada, K|Akamatsu, T|Uchida, T|Tatsuguchi, A|Matsui, H|Fukui, H|Fujimori, T|Kasuga, M | ||||||||||
| PMID: | 10535875 | ||||||||||
| 3. | |||||||||||
| Journal: | J Biol Chem. 2002 Apr 5;277(14):11918-26. | ||||||||||
| Title: | Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7. | ||||||||||
| Author: | Pero, Stephanie C|Oligino, Lyn|Daly, Roger J|Soden, Amy L|Liu, Chen|Roller, Peter P|Li, Peng|Krag, David N | ||||||||||
| PMID: | 11809769 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncogene. 2003 Mar 6;22(9):1294-301. | ||||||||||
| Title: | Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas. | ||||||||||
| Author: | Kobayashi, Michimoto|Iwamatsu, Akihiro|Shinohara-Kanda, Azusa|Ihara, Sayoko|Fukui, Yasuhisa | ||||||||||
| PMID: | 12618754 | ||||||||||
| 5. | |||||||||||
| Journal: | Int J Cancer. 2006 Mar 15;118(6):1426-9. | ||||||||||
| Title: | Somatic mutations of the ERBB4 kinase domain in human cancers. | ||||||||||
| Author: | Soung, Young Hwa|Lee, Jong Woo|Kim, Su Young|Wang, Young Pil|Jo, Keon Hyun|Moon, Seok Whan|Park, Won Sang|Nam, Suk Woo|Lee, Jung Young|Yoo, Nam Jin|Lee, Sug Hyung | ||||||||||
| PMID: | 16187281 | ||||||||||
| 6. | |||||||||||
| Journal: | Carcinogenesis. 2008 Apr;29(4):704-12. | ||||||||||
| Title: | Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. | ||||||||||
| Author: | Kim, Kwang-Kyu|Lee, Jung Joon|Yang, Young|You, Kwan-Hee|Lee, Jeong-Hyung | ||||||||||
| PMID: | 18258606 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Res. 2008 Apr 1;68(7):2340-8. | ||||||||||
| Title: | FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. | ||||||||||
| Author: | Kunii, Kaiko|Davis, Lenora|Gorenstein, Julie|Hatch, Harold|Yashiro, Masakazu|Di Bacco, Alessandra|Elbi, Cem|Lutterbach, Bart | ||||||||||
| PMID: | 18381441 | ||||||||||
| 8. | |||||||||||
| Journal: | Clin Cancer Res. 2008 Dec 1;14(23):7843-9. | ||||||||||
| Title: | High expression of HER3 is associated with a decreased survival in gastric cancer. | ||||||||||
| Author: | Hayashi, Mikiko|Inokuchi, Mikito|Takagi, Yoko|Yamada, Hiroyuki|Kojima, Kazuyuki|Kumagai, Jiro|Kawano, Tatsuyuki|Sugihara, Kenichi | ||||||||||
| PMID: | 19047113 | ||||||||||
| 9. | |||||||||||
| Journal: | Anat Rec (Hoboken). 2009 Feb;292(2):262-70. | ||||||||||
| Title: | Gene expression profiling in TWIST-depleted gastric cancer cells. | ||||||||||
| Author: | Feng, Mei-Yan|Wang, Kuan|Shi, Qing-Tao|Yu, Xiu-Wen|Geng, Jing-Shu | ||||||||||
| PMID: | 19051271 | ||||||||||
| 10. | |||||||||||
| Journal: | World J Surg. 2009 Oct;33(10):2112-8. | ||||||||||
| Title: | Comparative study on overexpression of HER2/neu and HER3 in gastric cancer. | ||||||||||
| Author: | Zhang, Xiu Li|Yang, Yun Sheng|Xu, Dong Ping|Qu, Jian Hui|Guo, Ming Zhou|Gong, Yan|Huang, Jin | ||||||||||
| PMID: | 19636613 | ||||||||||
| 11. | |||||||||||
| Journal: | Mol Cancer Ther. 2009 Sep;8(9):2526-36. | ||||||||||
| Title: | Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells. | ||||||||||
| Author: | Yoon, Young-Kwang|Kim, Hwang-Phill|Han, Sae-Won|Hur, Hyung-Seok|Oh, Do Youn|Im, Seock-Ah|Bang, Yung-Jue|Kim, Tae-You | ||||||||||
| PMID: | 19755509 | ||||||||||
| 12. | |||||||||||
| Journal: | Mol Cancer. 2010 May 26;9:121. | ||||||||||
| Title: | Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition. | ||||||||||
| Author: | Corso, Simona|Ghiso, Elena|Cepero, Virna|Sierra, J Rafael|Migliore, Cristina|Bertotti, Andrea|Trusolino, Livio|Comoglio, Paolo M|Giordano, Silvia | ||||||||||
| PMID: | 20500904 | ||||||||||
| 13. | |||||||||||
| Journal: | J Mol Med (Berl). 2010 Nov;88(11):1113-21. | ||||||||||
| Title: | Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes. | ||||||||||
| Author: | Meyerhuber, Peter|Conrad, Heinke|Starck, Lilian|Leisegang, Matthias|Busch, Dirk H|Uckert, Wolfgang|Bernhard, Helga | ||||||||||
| PMID: | 20700725 | ||||||||||
| 14. | |||||||||||
| Journal: | Surg Today. 2011 Jan;41(1):24-38. | ||||||||||
| Title: | Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. | ||||||||||
| Author: | Yamashita, Keishi|Sakuramoto, Shinichi|Watanabe, Masahiko | ||||||||||
| PMID: | 21191688 | ||||||||||
| 15. | |||||||||||
| Journal: | Clin Cancer Res. 2011 Aug 1;17(15):5060-70. | ||||||||||
| Title: | Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models. | ||||||||||
| Author: | Yamashita-Kashima, Yoriko|Iijima, Shigeyuki|Yorozu, Keigo|Furugaki, Koh|Kurasawa, Mitsue|Ohta, Masateru|Fujimoto-Ouchi, Kaori | ||||||||||
| PMID: | 21700765 | ||||||||||
| 16. | |||||||||||
| Journal: | J Clin Oncol. 2011 Aug 1;29(22):3030-6. | ||||||||||
| Title: | Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. | ||||||||||
| Author: | Begnami, Maria D|Fukuda, Emy|Fregnani, Jose H T G|Nonogaki, Suely|Montagnini, Andre L|da Costa, Wilson L Jr|Soares, Fernando A | ||||||||||
| PMID: | 21709195 | ||||||||||
| 17. | |||||||||||
| Journal: | Gastroenterology. 2011 Nov;141(5):1738-48.e1-2. | ||||||||||
| Title: | DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. | ||||||||||
| Author: | Zhu, Shoumin|Belkhiri, Abbes|El-Rifai, Wael | ||||||||||
| PMID: | 21741919 | ||||||||||
| 18. | |||||||||||
| Journal: | Mol Cancer Ther. 2012 Feb;11(2):439-51. | ||||||||||
| Title: | Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer. | ||||||||||
| Author: | Nam, Hyun-Jin|Ching, Keith A|Kan, Julie|Kim, Hwang-Phill|Han, Sae-Won|Im, Seock-Ah|Kim, Tae-You|Christensen, James G|Oh, Do-Youn|Bang, Yung-Jue | ||||||||||
| PMID: | 22135232 | ||||||||||
| 19. | |||||||||||
| Journal: | Invest New Drugs. 2012 Aug;30(4):1352-60. | ||||||||||
| Title: | Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks. | ||||||||||
| Author: | Kataoka, Yu|Mukohara, Toru|Tomioka, Hideo|Funakoshi, Yohei|Kiyota, Naomi|Fujiwara, Yutaka|Yashiro, Masakazu|Hirakawa, Kosei|Hirai, Midori|Minami, Hironobu | ||||||||||
| PMID: | 21655918 | ||||||||||
| 20. | |||||||||||
| Journal: | Curr Pharm Des. 2013;19(5):958-64. | ||||||||||
| Title: | Irinotecan resistance is accompanied by upregulation of EGFR and Src signaling in human cancer models. | ||||||||||
| Author: | Petitprez, Amelie|Larsen, Annette K | ||||||||||
| PMID: | 22973964 | ||||||||||
| 21. | |||||||||||
| Journal: | Gut Microbes. 2013 Nov-Dec;4(6):454-74. | ||||||||||
| Title: | Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells. | ||||||||||
| Author: | Pachathundikandi, Suneesh Kumar|Tegtmeyer, Nicole|Backert, Steffen | ||||||||||
| PMID: | 24280762 | ||||||||||
| 22. | |||||||||||
| Journal: | Nat Rev Clin Oncol. 2013 Nov;10(11):643-55. | ||||||||||
| Title: | Gastric cancer-molecular and clinical dimensions. | ||||||||||
| Author: | Wadhwa, Roopma|Song, Shumei|Lee, Ju-Seog|Yao, Yixin|Wei, Qingyi|Ajani, Jaffer A | ||||||||||
| PMID: | 24061039 | ||||||||||
| 23. | |||||||||||
| Journal: | Cancer Res. 2013 Oct 1;73(19):6013-23. | ||||||||||
| Title: | Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110alpha inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers. | ||||||||||
| Author: | Garrett, Joan T|Sutton, Cammie R|Kurupi, Richard|Bialucha, Carl Uli|Ettenberg, Seth A|Collins, Scott D|Sheng, Qing|Wallweber, Jerry|Defazio-Eli, Lisa|Arteaga, Carlos L | ||||||||||
| PMID: | 23918797 | ||||||||||
| 24. | |||||||||||
| Journal: | Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jul;16(7):668-72. | ||||||||||
| Title: | [Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer]. | ||||||||||
| Author: | Li, Gang|Gu, Rong-min|Wen, Xu|Ming, Xue-zhi|Xia, Lei|Xu, Xin-yu|Zhang, Ji|Chen, Huan-qiu | ||||||||||
| PMID: | 23888453 | ||||||||||
| 25. | |||||||||||
| Journal: | J Biol Chem. 2013 Aug 30;288(35):25254-64. | ||||||||||
| Title: | Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface. | ||||||||||
| Author: | Collier, Timothy S|Diraviyam, Karthikeyan|Monsey, John|Shen, Wei|Sept, David|Bose, Ron | ||||||||||
| PMID: | 23843458 | ||||||||||
| 26. | |||||||||||
| Journal: | Oncol Rep. 2013 Sep;30(3):1087-93. | ||||||||||
| Title: | Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model. | ||||||||||
| Author: | Yamashita-Kashima, Yoriko|Shu, Sei|Harada, Naoki|Fujimoto-Ouchi, Kaori | ||||||||||
| PMID: | 23783223 | ||||||||||
| 27. | |||||||||||
| Journal: | Mol Cancer Ther. 2013 May;12(5):737-46. | ||||||||||
| Title: | Y-box binding protein-1 contributes to both HER2/ErbB2 expression and lapatinib sensitivity in human gastric cancer cells. | ||||||||||
| Author: | Shibata, Tomohiro|Kan, Hitoshi|Murakami, Yuichi|Ureshino, Hiroki|Watari, Kosuke|Kawahara, Akihiko|Kage, Masayoshi|Hattori, Satoshi|Ono, Mayumi|Kuwano, Michihiko | ||||||||||
| PMID: | 23445612 | ||||||||||
| 28. | |||||||||||
| Journal: | PLoS One. 2013;8(1):e54644. | ||||||||||
| Title: | A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers. | ||||||||||
| Author: | Lee, Jeeyun|Kim, Sung|Kim, Phillip|Liu, Xinjun|Lee, Tani|Kim, Kyoung-Mee|Do, In-Gu|Park, Joon Oh|Park, Se Hoon|Jang, Jiryeon|Hoe, Nicholas|Harvie, Gulia|Kuller, Anne|Jain, Anjali|Meyer, Gary|Leesman, Glen|Park, Young Suk|Choi, Min Gew|Sohn, Tae Sung|Bae, | ||||||||||
| PMID: | 23372746 | ||||||||||
| 29. | |||||||||||
| Journal: | J Natl Cancer Inst. 2013 Feb 20;105(4):266-73. | ||||||||||
| Title: | HER3 overexpression and survival in solid tumors: a meta-analysis. | ||||||||||
| Author: | Ocana, Alberto|Vera-Badillo, Francisco|Seruga, Bostjan|Templeton, Arnoud|Pandiella, Atanasio|Amir, Eitan | ||||||||||
| PMID: | 23221996 | ||||||||||
| 30. | |||||||||||
| Journal: | Cancer Sci. 2014 Dec;105(12):1591-600. | ||||||||||
| Title: | Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer. | ||||||||||
| Author: | Ema, Akira|Yamashita, Keishi|Ushiku, Hideki|Kojo, Ken|Minatani, Naoko|Kikuchi, Mariko|Mieno, Hiroaki|Moriya, Hiromitsu|Hosoda, Kei|Katada, Natsuya|Kikuchi, Shiro|Watanabe, Masahiko | ||||||||||
| PMID: | 25455899 | ||||||||||
| 31. | |||||||||||
| Journal: | Oncotarget. 2014 Nov 15;5(21):10222-36. | ||||||||||
| Title: | Regulation of ERBB3/HER3 signaling in cancer. | ||||||||||
| Author: | Mujoo, Kalpana|Choi, Byung-Kwon|Huang, Zhao|Zhang, Ningyan|An, Zhiqiang | ||||||||||
| PMID: | 25400118 | ||||||||||
| 32. | |||||||||||
| Journal: | Mol Clin Oncol. 2014 Nov;2(6):1160-1166. | ||||||||||
| Title: | Expression of acidosis-dependent genes in human cancer nests. | ||||||||||
| Author: | Fukamachi, Toshihiko|Ikeda, Shunsuke|Saito, Hiromi|Tagawa, Masatoshi|Kobayashi, Hiroshi | ||||||||||
| PMID: | 25279216 | ||||||||||
| 33. | |||||||||||
| Journal: | Biomed Pharmacother. 2014 Jul;68(6):809-12. | ||||||||||
| Title: | The role of HER3 in gastric cancer. | ||||||||||
| Author: | Wang, Liying|Yuan, Hengheng|Li, Yanjing|Han, Yu | ||||||||||
| PMID: | 25194439 | ||||||||||
| 34. | |||||||||||
| Journal: | Clin Cancer Res. 2014 Sep 1;20(17):4559-73. | ||||||||||
| Title: | Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer. | ||||||||||
| Author: | Zhang, Zhe|Wang, Jiping|Ji, Dongmei|Wang, Chenchen|Liu, Rujiao|Wu, Zheng|Liu, Lian|Zhu, Dan|Chang, Jinjia|Geng, Ruixuan|Xiong, Lei|Fang, Qiangyi|Li, Jin | ||||||||||
| PMID: | 24973425 | ||||||||||
| 35. | |||||||||||
| Journal: | APMIS. 2014 Dec;122(12):1207-12. | ||||||||||
| Title: | Mutational and expressional analysis of ERBB3 gene in common solid cancers. | ||||||||||
| Author: | Choi, Mi Ryoung|An, Chang Hyeok|Chung, Yeun Jun|Choi, Youn Jin|Yoo, Nam Jin|Lee, Sug Hyung | ||||||||||
| PMID: | 24909266 | ||||||||||
| 36. | |||||||||||
| Journal: | Int J Clin Exp Pathol. 2014 Mar 15;7(4):1449-58. eCollection 2014. | ||||||||||
| Title: | AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel. | ||||||||||
| Author: | Wu, Gang|Qin, Xue-Qian|Guo, Jing-Jing|Li, Tian-Yi|Chen, Jin-Hong | ||||||||||
| PMID: | 24817940 | ||||||||||
| 37. | |||||||||||
| Journal: | PLoS One. 2014 Apr 11;9(4):e94606. | ||||||||||
| Title: | Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4. | ||||||||||
| Author: | Nielsen, Trine Ostergaard|Friis-Hansen, Lennart|Poulsen, Steen Seier|Federspiel, Birgitte|Sorensen, Boe Sandahl | ||||||||||
| PMID: | 24728052 | ||||||||||
| 38. | |||||||||||
| Journal: | Recent Results Cancer Res. 2014;201:125-43. | ||||||||||
| Title: | Lapatinib. | ||||||||||
| Author: | Nolting, Minna|Schneider-Merck, Tanja|Trepel, Martin | ||||||||||
| PMID: | 24756789 | ||||||||||
| 39. | |||||||||||
| Journal: | Gastric Cancer. 2014 Jan;17(1):76-86. | ||||||||||
| Title: | Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors. | ||||||||||
| Author: | Jacome, Alexandre Andrade Anjos|Wohnrath, Durval R|Scapulatempo Neto, Cristovam|Carneseca, Estela C|Serrano, Sergio V|Viana, Luciano Souza|Nunes, Joao S|Martinez, Edson Z|Santos, Jose Sebastiao | ||||||||||
| PMID: | 23455716 | ||||||||||
| 40. | |||||||||||
| Journal: | Oncogene. 2014 Jun 19;33(25):3334-41. | ||||||||||
| Title: | Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer. | ||||||||||
| Author: | Kim, H-P|Han, S-W|Song, S-H|Jeong, E-G|Lee, M-Y|Hwang, D|Im, S-A|Bang, Y-J|Kim, T-Y | ||||||||||
| PMID: | 23873022 | ||||||||||
| 41. | |||||||||||
| Journal: | Med Oncol. 2014 Apr;31(4):903. | ||||||||||
| Title: | Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway. | ||||||||||
| Author: | Wu, Xiaoyu|Chen, Yun|Li, Gang|Xia, Lei|Gu, Rongmin|Wen, Xu|Ming, Xuezhi|Chen, Huanqiu | ||||||||||
| PMID: | 24623015 | ||||||||||
| 42. | |||||||||||
| Journal: | Mol Clin Oncol. 2014 Mar;2(2):175-181. | ||||||||||
| Title: | Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review). | ||||||||||
| Author: | Shimoyama, Shouji | ||||||||||
| PMID: | 24649329 | ||||||||||
| 43. | |||||||||||
| Journal: | MAbs. 2014 Mar-Apr;6(2):403-8. | ||||||||||
| Title: | The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancer. | ||||||||||
| Author: | Han, Siqi|Meng, Yanchun|Tong, Qing|Li, Guangchao|Zhang, Xunmin|Chen, Yalin|Hu, Shi|Zheng, Lei|Tan, Wenlong|Li, Hui|Chen, Yang|Zhang, Ge|Li, Bohua|Guo, Yajun | ||||||||||
| PMID: | 24492292 | ||||||||||
| 44. | |||||||||||
| Journal: | Int J Mol Sci. 2015 Aug 17;16(8):19447-57. | ||||||||||
| Title: | Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma. | ||||||||||
| Author: | Gonzalez-Alonso, Paula|Chamizo, Cristina|Moreno, Victor|Madoz-Gurpide, Juan|Carvajal, Nerea|Daoud, Lina|Zazo, Sandra|Martin-Aparicio, Ester|Cristobal, Ion|Rincon, Raul|Garcia-Foncillas, Jesus|Rojo, Federico | ||||||||||
| PMID: | 26287187 | ||||||||||
| 45. | |||||||||||
| Journal: | Oncotarget. 2015 Dec 15;6(40):42868-78. | ||||||||||
| Title: | HER3 over-expression and overall survival in gastrointestinal cancers. | ||||||||||
| Author: | Wang, Yadong|Yang, Haiyan|Duan, Guangcai | ||||||||||
| PMID: | 26517355 | ||||||||||
| 46. | |||||||||||
| Journal: | Clin Cancer Res. 2015 Dec 15;21(24):5519-31. | ||||||||||
| Title: | Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas. | ||||||||||
| Author: | Leto, Simonetta M|Sassi, Francesco|Catalano, Irene|Torri, Valter|Migliardi, Giorgia|Zanella, Eugenia R|Throsby, Mark|Bertotti, Andrea|Trusolino, Livio | ||||||||||
| PMID: | 26296355 | ||||||||||
| 47. | |||||||||||
| Journal: | PLoS One. 2015 Jul 28;10(7):e0134493. | ||||||||||
| Title: | Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity. | ||||||||||
| Author: | Zhang, Tianwei|Zhang, Lin|Fan, Shuqiong|Zhang, Meizhuo|Fu, Haihua|Liu, Yuanjie|Yin, Xiaolu|Chen, Hao|Xie, Liang|Zhang, Jingchuan|Gavine, Paul R|Gu, Yi|Ni, Xingzhi|Su, Xinying | ||||||||||
| PMID: | 26217940 | ||||||||||
| 48. | |||||||||||
| Journal: | J Clin Pathol. 2015 May;68(5):374-80. | ||||||||||
| Title: | Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. | ||||||||||
| Author: | He, Xiao Xiao|Ding, Li|Lin, Yuan|Shu, Man|Wen, Jian Ming|Xue, Ling | ||||||||||
| PMID: | 25731189 | ||||||||||
| 49. | |||||||||||
| Journal: | Oncotarget. 2015 Feb 10;6(4):2009-22. | ||||||||||
| Title: | Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer. | ||||||||||
| Author: | Chang, Jinjia|Wang, Shanshan|Zhang, Zhe|Liu, Xinyang|Wu, Zheng|Geng, Ruixuan|Ge, Xiaoxiao|Dai, Congqi|Liu, Rujiao|Zhang, Qunling|Li, Wenhua|Li, Jin | ||||||||||
| PMID: | 25576915 | ||||||||||
| 50. | |||||||||||
| Journal: | Onco Targets Ther. 2014 Dec 16;8:7-14. | ||||||||||
| Title: | Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas. | ||||||||||
| Author: | Tang, Daoqiang|Liu, Charles Yj|Shen, Danping|Fan, Shuqiong|Su, Xinying|Ye, Peng|Gavine, Paul R|Yin, Xiaolu | ||||||||||
| PMID: | 25565860 | ||||||||||
| 51. | |||||||||||
| Journal: | Mol Carcinog. 2015 Dec;54(12):1700-9. | ||||||||||
| Title: | Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer. | ||||||||||
| Author: | Yun, Chen|Gang, Li|Rongmin, Gu|Xu, Wen|Xuezhi, Ming|Huanqiu, Chen | ||||||||||
| PMID: | 25400108 | ||||||||||
| 52. | |||||||||||
| Journal: | Mol Oncol. 2015 Feb;9(2):398-408. | ||||||||||
| Title: | Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer. | ||||||||||
| Author: | Ko, Bong-Kook|Lee, Sook-Yeon|Lee, Young-Ha|Hwang, In-Sik|Persson, Helena|Rockberg, Johan|Borrebaeck, Carl|Park, Dongeun|Kim, Kyu-Tae|Uhlen, Mathias|Lee, Jong-Seo | ||||||||||
| PMID: | 25306393 | ||||||||||
| 53. | |||||||||||
| Journal: | Cell Death Dis. 2016 Oct 27;7(10):e2442. | ||||||||||
| Title: | Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer. | ||||||||||
| Author: | Shi, Jing|Qu, Yiping|Li, Xinru|Sui, Fang|Yao, Demao|Yang, Qi|Shi, Bingyin|Ji, Meiju|Hou, Peng | ||||||||||
| PMID: | 27787520 | ||||||||||
| 54. | |||||||||||
| Journal: | Oncotarget. 2016 Dec 20;7(51):84860-84871. | ||||||||||
| Title: | Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1. | ||||||||||
| Author: | Nonagase, Yoshikane|Yonesaka, Kimio|Kawakami, Hisato|Watanabe, Satomi|Haratani, Koji|Takahama, Takayuki|Takegawa, Naoki|Ueda, Hiroto|Tanizaki, Junko|Hayashi, Hidetoshi|Yoshida, Takeshi|Takeda, Masayuki|Chiba, Yasutaka|Tamura, Takao|Nakagawa, Kazuhiko|Tsur | ||||||||||
| PMID: | 27768588 | ||||||||||
| 55. | |||||||||||
| Journal: | Expert Opin Biol Ther. 2016 Dec;16(12):1549-1555. | ||||||||||
| Title: | The prospect of patritumab for treating non-small cell lung cancer. | ||||||||||
| Author: | Horinouchi, Hidehito | ||||||||||
| PMID: | 27744717 | ||||||||||
| 56. | |||||||||||
| Journal: | PLoS One. 2016 Aug 18;11(8):e0161219. | ||||||||||
| Title: | HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis. | ||||||||||
| Author: | Cao, Guo-Dong|Chen, Ke|Xiong, Mao-Ming|Chen, Bo | ||||||||||
| PMID: | 27536774 | ||||||||||
| 57. | |||||||||||
| Journal: | Mol Cancer Ther. 2016 Sep;15(9):2251-8. | ||||||||||
| Title: | A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer. | ||||||||||
| Author: | LaBonte, Melissa J|Yang, Dongyun|Zhang, Wu|Wilson, Peter M|Nagarwala, Yasir M|Koch, Kevin M|Briner, Colleen|Kaneko, Tomomi|Rha, Sun-Young|Gladkov, Oleg|Urba, Susan G|Sakaeva, Dina|Pishvaian, Michael J|Hsieh, Ruey-Kuen|Lee, Wei-Ping|Lenz, Heinz-Josef | ||||||||||
| PMID: | 27325685 | ||||||||||
| 58. | |||||||||||
| Journal: | Cancer Lett. 2016 Sep 28;380(1):20-30. | ||||||||||
| Title: | The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer. | ||||||||||
| Author: | Wang, Qiwei|Zhang, Xiaotian|Shen, Enyun|Gao, Jing|Cao, Fengqi|Wang, Xiaojuan|Li, Yilin|Tian, Tiantian|Wang, Jingyuan|Chen, Zuhua|Wang, Jiayuan|Shen, Lin | ||||||||||
| PMID: | 27317872 | ||||||||||
| 59. | |||||||||||
| Journal: | Anticancer Res. 2016 Apr;36(4):1581-90. | ||||||||||
| Title: | HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study. | ||||||||||
| Author: | Makatsoris, Thomas|Tsamandas, Athanassios C|Strimpakos, Alexios|Alexopoulou, Zoi|Dionysopoulos, Dimitrios|Pervana, Stavroula|Konstantara, Athina|Papakostas, Pavlos|Samantas, Epaminontas|Rallis, Grigoris|Dimou, Anastasios|Pentheroudakis, George|Papaparaske | ||||||||||
| PMID: | 27069134 | ||||||||||
| 60. | |||||||||||
| Journal: | Oncotarget. 2016 Apr 19;7(16):21601-17. | ||||||||||
| Title: | APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis. | ||||||||||
| Author: | Hong, Se-Hoon|Lee, Won Jae|Kim, Young Doo|Kim, Hyunjoo|Jeon, Young-Jun|Lim, Bitna|Cho, Dong-Hyung|Heo, Won Do|Yang, Doo-Hyun|Kim, Chan-Young|Yang, Han-Kwang|Yang, Jin Kuk|Jung, Yong-Keun | ||||||||||
| PMID: | 26942872 | ||||||||||
| 61. | |||||||||||
| Journal: | Oncotarget. 2016 Apr 5;7(14):18424-39. | ||||||||||
| Title: | Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer. | ||||||||||
| Author: | Arienti, Chiara|Zanoni, Michele|Pignatta, Sara|Del Rio, Alberto|Carloni, Silvia|Tebaldi, Michela|Tedaldi, Gianluca|Tesei, Anna | ||||||||||
| PMID: | 26919099 | ||||||||||
| 62. | |||||||||||
| Journal: | Expert Opin Biol Ther. 2016;16(2):243-53. | ||||||||||
| Title: | Pertuzumab in gastrointestinal cancer. | ||||||||||
| Author: | Oh, Do-Youn|Bang, Yung-Jue | ||||||||||
| PMID: | 26619359 | ||||||||||
| 63. | |||||||||||
| Journal: | J Pathol. 2016 Oct;240(2):137-48. | ||||||||||
| Title: | Comprehensive mutation profiling of mucinous gastric carcinoma. | ||||||||||
| Author: | Rokutan, Hirofumi|Hosoda, Fumie|Hama, Natsuko|Nakamura, Hiromi|Totoki, Yasushi|Furukawa, Eisaku|Arakawa, Erika|Ohashi, Shoko|Urushidate, Tomoko|Satoh, Hironori|Shimizu, Hiroko|Igarashi, Keiko|Yachida, Shinichi|Katai, Hitoshi|Taniguchi, Hirokazu|Fukayama, | ||||||||||
| PMID: | 27313181 | ||||||||||
| 64. | |||||||||||
| Journal: | BMC Cancer. 2017 Sep 12;17(1):646. | ||||||||||
| Title: | A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. | ||||||||||
| Author: | Reynolds, Kerry Lynn|Bedard, Philippe L|Lee, Se-Hoon|Lin, Chia-Chi|Tabernero, Josep|Alsina, Maria|Cohen, Ezra|Baselga, Jose|Blumenschein, George Jr|Graham, Donna M|Garrido-Laguna, Ignacio|Juric, Dejan|Sharma, Sunil|Salgia, Ravi|Seroutou, Abdelkader|Tian, | ||||||||||
| PMID: | 28899363 | ||||||||||
| 65. | |||||||||||
| Journal: | BMC Cancer. 2017 Dec 12;17(1):841. | ||||||||||
| Title: | Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients. | ||||||||||
| Author: | Cao, Guo-Dong|Chen, Ke|Chen, Bo|Xiong, Mao-Ming | ||||||||||
| PMID: | 29233126 | ||||||||||
| 66. | |||||||||||
| Journal: | Oncotarget. 2017 May 18;8(40):67140-67151. | ||||||||||
| Title: | Prognostic significance of HER3 in patients with malignant solid tumors. | ||||||||||
| Author: | Li, Qin|Zhang, RuiXue|Yan, Han|Zhao, PengFei|Wu, Li|Wang, Hui|Li, Teng|Cao, Bangwei | ||||||||||
| PMID: | 28978022 | ||||||||||
| 67. | |||||||||||
| Journal: | Cancer Cell Int. 2017 Sep 13;17:81. | ||||||||||
| Title: | SNP rs3202538 in 3'UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population. | ||||||||||
| Author: | Shi, Yaxiang|Chen, Xuan|Xi, Biao|Yu, Xiaowen|Ouyang, Jun|Han, Chunxia|Qin, Yucheng|Wu, Defeng|Shen, Hong | ||||||||||
| PMID: | 28924391 | ||||||||||
| 68. | |||||||||||
| Journal: | Oncotarget. 2017 Apr 29;8(32):52584-52593. | ||||||||||
| Title: | siRNA-mediated inactivation of HER3 improves the antitumour activity and sensitivity of gefitinib in gastric cancer cells. | ||||||||||
| Author: | Yuan, Heng-Heng|Yang, Ying-Nan|Zhou, Jian-Hua|Li, Yan-Jing|Wang, Li-Ying|Qin, Jun-Wei|Liu, Tao|Li, Zhen-Zhen|Zhou, Qing-Xin|Wei, Xiao-Li|Zhang, Ting-Ting|Huang, Peng|Zhang, Wen-Jie|Liu, Lei|Du, Xiao-Xue|Han, Yu | ||||||||||
| PMID: | 28881753 | ||||||||||
| 69. | |||||||||||
| Journal: | Gastroenterology. 2017 Aug;153(2):536-549.e26. | ||||||||||
| Title: | Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. | ||||||||||
| Author: | Cho, Soo Young|Park, Jun Won|Liu, Yang|Park, Young Soo|Kim, Ju Hee|Yang, Hanna|Um, Hyejin|Ko, Woo Ri|Lee, Byung Il|Kwon, Sun Young|Ryu, Seung Wan|Kwon, Chae Hwa|Park, Do Youn|Lee, Jae-Hyuk|Lee, Sang Il|Song, Kyu Sang|Hur, Hoon|Han, Sang-Uk|Chang, Heekyung | ||||||||||
| PMID: | 28522256 | ||||||||||
| 70. | |||||||||||
| Journal: | Pathobiology. 2017;84(4):210-217. | ||||||||||
| Title: | Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer. | ||||||||||
| Author: | Byeon, Sun-Ju|Lee, Hye Seung|Kim, Min-A|Lee, Byung Lan|Kim, Woo Ho | ||||||||||
| PMID: | 28399526 | ||||||||||
| 71. | |||||||||||
| Journal: | Cancer Metastasis Rev. 2017 Mar;36(1):141-157. | ||||||||||
| Title: | HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? | ||||||||||
| Author: | Galdy, Salvatore|Lamarca, Angela|McNamara, Mairead G|Hubner, Richard A|Cella, Chiara A|Fazio, Nicola|Valle, Juan W | ||||||||||
| PMID: | 27981460 | ||||||||||
| 72. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2017 Jan;79(1):131-138. | ||||||||||
| Title: | LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer. | ||||||||||
| Author: | Takahashi, Shunji|Kobayashi, Takayuki|Tomomatsu, Junichi|Ito, Yoshinori|Oda, Hisanobu|Kajitani, Tatsuhiro|Kakizume, Tomoyuki|Tajima, Takeshi|Takeuchi, Hiromi|Maacke, Heiko|Esaki, Taito | ||||||||||
| PMID: | 27942917 | ||||||||||
| 73. | |||||||||||
| Journal: | Gastric Cancer. 2018 Mar;21(2):225-236. | ||||||||||
| Title: | Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients. | ||||||||||
| Author: | Yun, Sumi|Koh, Jiwon|Nam, Soo Kyung|Park, Jung Ok|Lee, Sung Mi|Lee, Kyoungyul|Lee, Kyu Sang|Ahn, Sang-Hoon|Park, Do Joong|Kim, Hyung-Ho|Choe, Gheeyoung|Kim, Woo Ho|Lee, Hye Seung | ||||||||||
| PMID: | 28573357 | ||||||||||
| 74. | |||||||||||
| Journal: | Cell Biol Int. 2018 Jan;42(1):53-62. | ||||||||||
| Title: | 4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation. | ||||||||||
| Author: | Shi, Xiaonan|Zheng, Chunlei|Li, Ce|Hou, Kezuo|Wang, Xiaoxun|Yang, Zichang|Liu, Chang|Liu, Yunpeng|Che, Xiaofang|Qu, Xiujuan | ||||||||||
| PMID: | 28851073 | ||||||||||
| 75. | |||||||||||
| Journal: | J Clin Pathol. 2018 May;71(5):451-462. | ||||||||||
| Title: | Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment. | ||||||||||
| Author: | Hedner, Charlotta|Borg, David|Nodin, Bjorn|Karnevi, Emelie|Jirstrom, Karin|Eberhard, Jakob | ||||||||||
| PMID: | 29138285 | ||||||||||
| 76. | |||||||||||
| Journal: | Oncol Lett. 2018 Feb;15(2):1758-1762. | ||||||||||
| Title: | Mechanisms for DNA-damaging agent-induced inactivation of ErbB2 and ErbB3 via the ERK and p38 signaling pathways. | ||||||||||
| Author: | Park, Chul Min|Kawasaki, Yuki|Refaat, Alaa|Sakurai, Hiroaki | ||||||||||
| PMID: | 29434871 | ||||||||||
| 77. | |||||||||||
| Journal: | Mol Cancer Ther. 2018 Jun;17(6):1259-1270. | ||||||||||
| Title: | Acquired Resistance to a MET Antibody In Vivo Can Be Overcome by the MET Antibody Mixture Sym015. | ||||||||||
| Author: | Pollmann, Sofie Ellebaek|Calvert, Valerie S|Rao, Shruti|Boca, Simina M|Madhavan, Subha|Horak, Ivan D|Kjaer, Andreas|Petricoin, Emanuel F|Kragh, Michael|Poulsen, Thomas Tuxen | ||||||||||
| PMID: | 29545332 | ||||||||||
| 78. | |||||||||||
| Journal: | Ann Surg Oncol. 2018 Jul;25(7):2027-2033. | ||||||||||
| Title: | Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer. | ||||||||||
| Author: | van Beek, Elke J A H|Hernandez, Jonathan M|Goldman, Debra A|Davis, Jeremy L|McLaughlin, Kaitlin|Ripley, R Taylor|Kim, Teresa S|Tang, Laura H|Hechtman, Jaclyn F|Zheng, Jian|Capanu, Marinela|Schultz, Nikolaus|Hyman, David M|Ladanyi, Marc|Berger, Michael F|S | ||||||||||
| PMID: | 29725898 | ||||||||||
| 79. | |||||||||||
| Journal: | Oncol Lett. 2018 Oct;16(4):4863-4870. | ||||||||||
| Title: | Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis. | ||||||||||
| Author: | Pan, Xuan|Ji, Xiaozhi|Zhang, Renmin|Zhou, Zhaofei|Zhong, Yuejiao|Peng, Wei|Sun, Ning|Xu, Xinyu|Xia, Lei|Li, Pansong|Lu, Jianwei|Tu, Jing | ||||||||||
| PMID: | 30250552 | ||||||||||